108 related articles for article (PubMed ID: 7985295)
1. [The prognostic value of flow cytometry in prostatic cancer].
Matveev BP; Bukharkin BV; Bogatyrev VN; Iurasova IV; Ataev AA; Bocharova OA; Mustia AI
Urol Nefrol (Mosk); 1994; (4):24-7. PubMed ID: 7985295
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
4. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
[TBL] [Abstract][Full Text] [Related]
6. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A
Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429
[TBL] [Abstract][Full Text] [Related]
10. [DNA flow cytometry in the prognostication of certain malignant neoformations].
Nikolaeva TG; Dobrynin IaV; Akhundov AA; Prorokov VV; Davydov MI
Vopr Onkol; 2001; 47(6):684-9. PubMed ID: 11826489
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
15. Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma.
Iwao Y; Kim YI; Kaketani K; Nakashima K; Okada K; Kobayashi M
Hepatogastroenterology; 1993 Oct; 40(5):491-5. PubMed ID: 8270242
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
[TBL] [Abstract][Full Text] [Related]
17. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
[TBL] [Abstract][Full Text] [Related]
19. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
